CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the best emerging technology stocks to buy right now. On September 3, Bank of ...

How did digits evolve? While it is clear that they derive from genetic programs already present in fish, their precise origin ...

Completed patient enrollment within nine months with nearly half enrolled from the U.S.Expect to report Phase 3 topline data in the first half of ...

September 18 has witnessed a remarkable array of events throughout history, spanning continents, cultures, and fields of ...

The global cell and gene therapy market is experiencing significant expansion, driven by rising approvals and advancements in ...

Genetic editing holds promise to treat incurable diseases, but the most popular method—CRISPR—sometimes does more harm than ...

Genetic editing holds promise to treat incurable diseases, but the most popular method - CRISPR - sometimes does more harm ...

Cell therapy refers to a treatment that involves the use of living cells to treat diseases. The cell therapy market has been ...

CRISPR Therapeutics AG is a long-term buy despite slow Casgevy uptake. Click for my updated look at CRSP earnings and the ...